Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Novartis to Open New Radioligand Therapy Manufacturing Facility in Indiana, USA
Novartis plans to open a new largescale, stateoftheart radioligand therapy RLT manufacturing facility in Indiana,USA The 70,000square foot site dedicated to RLT manufacturing stands
AGC Biologics Invests US$350 bn(¥50bn) to Construct New Manufacturing Site in Yokohama, Japan
AGC Biologics plans to construct a new manufacturing facility in Yokohama Japan The new facility, spanning four storeys and 20,000 square metres
Rentschler Biopharma to Open New Biopharma Manufacturing Facility in Massachusetts, USA
Rentschler Biopharma plans for the new biopharma manufacturing centre RBMC facility at its manufacturing site in Massachusetts, USA
BioNTech Invests US$150 million to Build mRNA Vaccine Manufacturing Facility in Rwanda, Africa
BioNTech is investing US$150 million to establish an mRNA vaccine manufacturing facility in Rwanda, Africa
BiomeBank Plans to Open a New State-of-the-Art GMP Facility in Adelaide, Australia
BiomeBank plans to open a new good manufacturing practise GMP facility to advance biomedical research and production in Adelaide, Australia
FUJIFILM Diosynth Biotechnologies Unveils US$200 million to Open New Manufcaturing Capacity in USA
FUJIFILM Diosynth Biotechnologies invests US$200 million to open new facility to expand cell therapy capabilities in USA
Full-Life Technologies Commences Construction on State-of-the-Art GMP Manufacturing Facility in Belgium, Europe
FullLife Technologies breaks ground for GMP manufacturing facility to advance its endtoend solution for radiopharmaceuticals in Belgium, Europe
Merck Invests US$31 million (€29 million) to Complete Biologics Testing Centre in Shanghai, China
Merck with an investment of US$31 million 29 million has completed the construction of new biologics testing centre in Shanghai, China
Eli Lilly Invests US$2.5 billion to Expand Injectable Manufacturing Capacity in Alzey, Germany
Eli Lilly plans to build a new US$25 billion cuttingedge manufacturing site in Alzey, Germany
Indiana University Invests US$250 million to Open Life Sciences Campus in Indianapolis, USA
Indiana University plans to invest US$250 million to open a new campus to advance scientific discoveries aimed at curing and treating diseases and improving human health
